1. DDIS-20. IMIPRIDONE STRUCTURE ACTIVITY RELATIONSHIP UNCOVERS ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR ONCOLOGY WITH DIFFERENTIATED RECEPTOR PHARMACOLOGY. (11th November 2019) Authors: Prabhu, Varun; Cuoco, Caroline; Jung, Jinkyu; Rahman Kawakibi, Abed; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Charter, Neil; Rucker, Joseph; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Gilbert, Mark; Benjamin Free, R; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-33. RECEPTOR PHARMACOLOGY OF ONC201: THE FIRST BITOPIC DRD2 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY. (11th November 2019) Authors: Benjamin Free, R; Cuoco, Caroline; Prabhu, Varun; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Sulli, Chidananda; Davidson, Edgar; Deacon, Sean; Rucker, Joseph; Charter, Neil; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Robert Lane, J; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗